Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer

Jul 1, 2009, 00:00
10.1111/j.1524-4733.2009.00564.x
https://www.valueinhealthjournal.com/article/S1098-3015(10)60724-3/fulltext
Title : Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60724-3&doi=10.1111/j.1524-4733.2009.00564.x
First page :
Section Title :
Open access? : No
Section Order : 25
Categories :
  • Cost/Cost of Illness/Resource Use Studies
  • Cost-comparison, Effectiveness, Utility, Benefit Analysis
  • Economic Evaluation
  • Oncology
  • Specific Diseases & Conditions
Tags :
Regions :
  • North America
ViH Article Tags :